Increased Orbital Muscle Fraction Diagnosed by Semi-Automatic Volumetry: A Risk Factor for Severe Visual Impairment with Excellent Response to Surgical Decompression in Graves’ Orbitopathy

Graves’ orbitopathy (GO) leads to increased orbital tissue and causes symptoms such as exophthalmos, functional complaints, or dysthyroid optic neuropathy. Different GO types with fat and/or muscle enlargement were identified, and increased muscle appears to particularly influence visual status and treatment response. The current study examines visual parameters dependent on orbital muscle volume fraction in a surgically treated GO cohort. After volumetric analysis of the preoperative orbital content, 83 orbits in 47 patients were categorized into predefined groups (increased or not-increased muscle fraction). All cases underwent pterional orbital decompression, and pre- and postoperative visual status was retrospectively analyzed. Forty-one orbits revealed increased and 42 orbits revealed not-increased muscle volume (mean fraction 29.63% versus (vs.) 15.60%). The preoperative visual acuity (VA) was significantly lower in orbits with increased vs. not-increased muscle volume (mean VA 0.30 vs. 0.53, difference 2.5 lines). After surgery, mean VA improved significantly by 1.7 lines in orbits with increased muscle volume. Not preoperative, but postoperative exophthalmos was significantly lower in orbits with not-increased muscle volume. Increased orbital muscle is associated with significantly reduced VA, but can be remarkably improved by pterional orbital decompression. Therefore, surgical therapy should be considered particularly in decreased VA with orbital muscle enlargement.

[1]  T. Ogawa,et al.  Comparison of the decompressive effect of different surgical procedures for dysthyroid optic neuropathy using 3D printed models , 2022, Graefe's Archive for Clinical and Experimental Ophthalmology.

[2]  Zhiyun Yang,et al.  Multiparametric quantitative MRI for the evaluation of dysthyroid optic neuropathy , 2021, European Radiology.

[3]  W. Wiersinga,et al.  THE 2021 EUROPEAN GROUP ON GRAVES' ORBITOPATHY (EUGOGO) CLINICAL PRACTICE GUIDELINES FOR THE MEDICAL MANAGEMENT OF GRAVES' ORBITOPATHY. , 2021, European journal of endocrinology.

[4]  M. Monteiro,et al.  A randomized comparative study of inferomedial vs. balanced orbital decompression. Analysis of changes in orbital volume, eyelid parameters, and eyeball position , 2021, Eye.

[5]  D. Boehringer,et al.  Pterional orbit decompression in Grave's disease with dysthyroid optic neuropathy. , 2021, World neurosurgery.

[6]  J. Ferri,et al.  Overview of tools for the measurement of the orbital volume and their applications to orbital surgery. , 2020, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[7]  J. Beenakker,et al.  The feasibility of quantitative MRI of extra‐ocular muscles in myasthenia gravis and Graves' orbitopathy , 2020, NMR in biomedicine.

[8]  R. Jacobs,et al.  Semi-automatic magnetic resonance imaging based orbital fat volumetry: reliability and correlation with computed tomography. , 2020, International journal of oral and maxillofacial surgery.

[9]  E. Drakonaki,et al.  Ex vivo orbital volumetry using stereology and CT imaging: A comparison with manual planimetry , 2018, European Radiology.

[10]  T. Nanda,et al.  Greater Proptosis Is Not Associated With Improved Compressive Optic Neuropathy in Thyroid Eye Disease. , 2018, Ophthalmic plastic and reconstructive surgery.

[11]  R. Ma,et al.  [Therapeutic outcomes and influence factors of maximal orbital decompression in the treatment of severe dysthyroid optic neuropathy]. , 2017, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology.

[12]  A. Stacey,et al.  Simultaneous Versus Staged Balanced Decompression for Thyroid-Related Compressive Optic Neuropathy , 2016, Ophthalmic plastic and reconstructive surgery.

[13]  W. Wiersinga,et al.  Some studies on the natural history of Graves' orbitopathy: increase in orbital fat is a rather late phenomenon. , 2015, European journal of endocrinology.

[14]  J. Byun,et al.  Surgical effects of various orbital decompression methods in thyroid-associated orbitopathy: computed tomography-based comparative analysis. , 2014, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[15]  P. Toft,et al.  Orbital Volumetry in Graves' Orbitopathy: Muscle and Fat Involvement in relation to Dysthyroid Optic Neuropathy , 2014, ISRN ophthalmology.

[16]  W. Wiersinga,et al.  Differential Involvement of Orbital Fat and Extraocular Muscles in Graves' Ophthalmopathy , 2013, European Thyroid Journal.

[17]  Jack Rootman,et al.  Quantitative computed tomographic predictors of compressive optic neuropathy in patients with thyroid orbitopathy: a volumetric analysis. , 2012, Ophthalmology.

[18]  M. Monteiro,et al.  Quantification of Orbital Apex Crowding for Screening of Dysthyroid Optic Neuropathy Using Multidetector CT , 2012, American Journal of Neuroradiology.

[19]  M. Stan,et al.  Risk factors for development or deterioration of Graves' ophthalmopathy. , 2010, Thyroid : official journal of the American Thyroid Association.

[20]  F. Zonneveld,et al.  Age and gender-specific reference values of orbital fat and muscle volumes in Caucasians , 2009, British Journal of Ophthalmology.

[21]  S. Leong,et al.  A systematic review of outcomes following surgical decompression for dysthyroid orbitopathy , 2009, The Laryngoscope.

[22]  S. Fook-Chong,et al.  Graves Ophthalmopathy: The Bony Orbit in Optic Neuropathy, Its Apical Angular Capacity, and Impact on Prediction of Risk , 2009, American Journal of Neuroradiology.

[23]  M. Nardi,et al.  Outcome of orbital decompression for disfiguring proptosis in patients with Graves’ orbitopathy using various surgical procedures , 2008, British Journal of Ophthalmology.

[24]  F. Zonneveld,et al.  A new and validated CT-based method for the calculation of orbital soft tissue volumes. , 2008, Investigative ophthalmology & visual science.

[25]  M. Nardi,et al.  Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. , 2008, Thyroid : official journal of the American Thyroid Association.

[26]  M. Nardi,et al.  Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. , 2008, European journal of endocrinology.

[27]  C. Dayan,et al.  Dysthyroid optic neuropathy: a clinical diagnosis or a definable entity? , 2007, British Journal of Ophthalmology.

[28]  Michele Marinò,et al.  Clinical features of dysthyroid optic neuropathy: a European Group on Graves’ Orbitopathy (EUGOGO) survey , 2006, British Journal of Ophthalmology.

[29]  F. Chabolle,et al.  Orbital Morphology in Exophthalmos and Exorbitism , 2006, Plastic and reconstructive surgery.

[30]  Maarten Ph Mourits,et al.  Radiologic Measurement of Extraocular Muscle Volumes in Patients with Graves' Orbitopathy: A Review and Guideline , 2006, Orbit.

[31]  J. Giaconi,et al.  CT Scan Evidence of Dysthyroid Optic Neuropathy , 2002, Ophthalmic plastic and reconstructive surgery.

[32]  E. Mezosi,et al.  Graves' ophthalmopathy: eye muscle involvement in patients with diplopia. , 2000, European journal of endocrinology.

[33]  D. Graeb,et al.  Graves orbitopathy: correlation of CT and clinical findings. , 1990, Radiology.

[34]  J. Patrinely,et al.  Dysthyroid optic neuropathy without extraocular muscle involvement. , 1989, Ophthalmic surgery.

[35]  S. Feldon,et al.  Graves' ophthalmopathy: I. Simple CT estimates of extraocular muscle volume. , 1988, The British journal of ophthalmology.

[36]  R M Burde,et al.  Optic nerve dysfunction in thyroid eye disease: CT. , 1988, Radiology.

[37]  W. Wiersinga,et al.  Do subtypes of graves' orbitopathy exist? , 2011, Ophthalmology.

[38]  J. Orcutt,et al.  Graves' ophthalmopathy. , 1992, The Western journal of medicine.

[39]  W. Wiersinga,et al.  Clinical presentation of Graves' ophthalmopathy. , 1989, Ophthalmic research.